High Risk | Low Risk | ||
---|---|---|---|
Number | 143 (61.9%) | 88 (38.1%) | |
Age | 59.9 ± 9.9 | 42.9 ± 9.8 | p = 0.000 |
Male | 81 (56.6%) | 53 (60.2%) | p = 0.592 |
Body Mass Index (Kg/m2) | 28.6 ± 5.4 | 26.4 ± 4.9 | p = 0.003 |
Cholesterol (mmol/L) | 4.11 ± 1.20 | 4.47 ± 1.22 | p = 0.037 |
High Density Lipoprotein (mmol/L) | 1.21 ± 0.47 | 1.28 ± 0.44 | p = 0.317 |
Triglycerides (mmol/L) | 1.68 ± 0.84 | 1.75 ± 1.16 | p = 0.668 |
Parathyroid Hormone Level (pmol/L) | 42.1 ± 48.9 | 40.5 ± 38.9 | p = 0.786 |
C-Reactive Protein (mg/L) | 9.4 ± 14.8 | 9.0 ± 14.7 | p = 0.834 |
Haemoglobin (g/L) | 107.8 ± 18.5 | 109.9 ± 15.9 | p = 0.391 |
Ferritin (μg/L) | 302.9 ± 293.9 | 250.5 ± 323.8 | p = 0.211 |
Modality | p = 0.121 | ||
Haemodialysis | 54 (37.8%) | 28 (31.8%) | |
Peritoneal Dialysis | 4 (2.8%) | 3 (3.4%) | |
Kidney Transplant | 8 (5.6%) | 13 (14.8%) | |
No Renal Replacement Therapy | 77 (53.8%) | 44 (50.0%) | |
Diabetes | 80 (55.9%) | 0 (0%) | p = 0.000 |
Hypertension | 135 (94.4%) | 76 (86.4%) | p = 0.035 |
Ischaemic Heart Disease | 29 (20.3%) | 2 (2.3%) | p = 0.000 |
Ever smoked | 54 (37.8%) | 31 (35.2%) | p = 0.481 |
Peripheral Vascular Disease | 4 (2.8%) | 0 (0%) | p = 0.113 |
Cerebrovascular Accident/TIA | 15 (10.5%) | 1 (1.1%) | p = 0.007 |
Congestive Cardiac Failure | 5 (3.5%) | 0 (0%) | p = 0.076 |
ACEi/ARB | 65 (45.5%) | 34 (38.6%) | p = 0.309 |
Antiplatelet | 54 (37.8%) | 5 (5.7%) | p = 0.000 |
Beta-Blocker | 43 (30.1%) | 27 (30.7%) | p = 0.922 |
Statin | 76 (53.1%) | 18 (20.5%) | p = 0.000 |
Average length of follow up (days) | 605.7 ± 294.8 | 568.5 ± 285.0 | p = 0.346 |